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Objective: Emotional problems are common in adults with diabetes, and knowledge about how different
indicators of emotional problems are related with glycemic control is required. The aim was to examine the
relationships of diabetes-speciﬁc emotional distress, depression, anxiety, and overall well-being with glycosylated
hemoglobin (HbA1c).
Methods: Of the 319 adults with type 1 diabetes attending the endocrinology outpatient clinic at a university
hospital in Norway, 235 (74%) completed the Diabetes Distress Scale, the Problem Areas in Diabetes Survey, the
Hospital Anxiety and Depression Scale, and the World Health Organization-Five Well-Being Index. Blood samples
were taken at the time of data collection to determine HbA1c. Regression analyses examined associations of
diabetes-speciﬁc emotional distress, anxiety, depression, and overall well-being with HbA1c. The relationship
between diabetes-speciﬁc emotional distress and HbA1c was tested for nonlinearity.
Results: Diabetes-speciﬁc emotional distress was related to glycemic control (DDS total: unstandardized
coefﬁcient = 0.038, P b .001; PAID total: coefﬁcient = 0.021, P = .007), but depression, anxiety, and overall
well-being were not. On the DDS, only regimen-related distress was independently related to HbA1c
(coefﬁcient = 0.056, P b .001). A difference of 0.5 standard deviation of baseline regimen distress is associated
with a difference of 0.6 in HbA1c. No signiﬁcant nonlinearity was detected in the relationship between diabetes-
speciﬁc distress and HbA1c.
Conclusions: To stimulate adequate care strategies, health personnel should acknowledge depression and diabetes-
speciﬁc emotional distress as different conditions in clinical consultations. Addressing diabetes-speciﬁc emotional
distress, in particular regimen distress, in clinical consultation might improve glycemic control.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Type 1 diabetes is a chronic disease where the insulin-producing
pancreatic beta cells are destroyed [1,2], which makes a lifetime
treatment of exogenous insulin replacement necessary [3]. Diabetes is
a growing public health burden across theworld [4], with consequences
for the individuals' daily lives [5], and substantial economic burden on
the society [6]. Maintaining an appropriate glycemic control is importanted Practice, Bergen University
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. This is an open access article underto prevent late complications of diabetes, such as diabetic retinopathy,
nephropathy and neuropathy [7]. The American Diabetes Association
guidelines [8] recommend that persons with type 1 diabetes should
have an HbA1c level of b7%. Despite the growing knowledge about what
might improve glycemic control, many persons do not meet the treat-
ment recommendation [9,10]. Emotional problems might complicate
the required self-management of the disease [11], and limit the persons'
management of self-care activities necessary to achieve an adequate
glycemic control [12]. The recent DAWN2 study showed that emotional
problems are a challenge of concern in persons with diabetes across
cultures [13]. Further it was reported that although the health care
providers acknowledged the importance of addressing emotional
problems inpersonswithdiabetes [14], therewas a gapbetweenpersons'
needs and current health care strategies [13].the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Table 1
Person characteristics of the 235 persons with type 1 diabetes.
Total, n 235
Male, n (%) 135 (57.4)
Female, n (%) 100 (42.6)
Age
Mean (SD) 39.0 (13.7)
Min–max, years 18–69
Diabetes duration, years
Mean (SD) 18.6 (12.0)
Min–max 1–58
HbA1c, %a mean (SD) 8.1 (1.6)
Presence of one or more late complicationb yes (%) 81 (40.3)
Education, n (%)
University, more than 4 years 30 (13.2)
University, up to 4 years 67 (29.4)
College/high school 104 (45.6)
Primary school, 9 years 27 (11.8)
DDS total meanc (SD) 19.5 (15.8)
DDS EBd (SD) 26.3 (22.4)
DDS RDd (SD) 23.6 (20.9)
DDS IDd (SD) 12.9 (17.3)
DDS PDd (SD) 10.7 (15.8)
PAID total meanc (SD) 23.6 (18.6)
WHO-5 total meanc (SD) 60 (19.8)
HADS-A meanc (SD) 5.6 (3.7)
HADS-D meanc (SD) 3.6 (3.5)
a Mmol/mol: 65.
b n = 201.
c DDS, PAID and WHO-5: 0–100 scale, HADS-A and HADS-D: 0–21 scales.
d The DDS subscales: the Emotional Burden subscale, the Regimen-related Distress
subscale, the diabetes-related Interpersonal Distress subscale, and the Physician-related
Distress subscale.
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a combination of these, might comprise barriers to adequate self-
management in persons with type 1 diabetes [15]. The underrecognition
of emotional problems, such as depression, anxiety, and diabetes-speciﬁc
emotional distress, has been reported [16], and when such concerns are
recognized, problems might be identiﬁed as depression, even in patients
whose problems are directly related to diabetes and its treatment [17].
Diabetes-speciﬁc emotional distress can be deﬁned as a range of
emotional responses and reactions to life with diabetes, especially
those related to the treatment regimen and self-care demands. It is
part of a person's experience of managing diabetes and its treatment
in the social context of family and health-care personnel [18–20]. In
contrast, depression is more strongly related to an anhedonic state, in
which an individual is markedly affected by feelings of sorrow and
hopelessness [21,22], and anxiety is predominantly related to fear,
worry, and dread [21].
Gonzales et al. [23] suggested that depression and diabetes-speciﬁc
emotional distress are independent constructs in type 2 diabetes, and
later proposed that there can be confusion regarding what is actually
addressed [17]. Hermanns et al. [24] showed that despite some overlap,
people with depression and those with diabetes-speciﬁc emotional
distress did not constitute identical groups in patients within type 1 or
type 2 diabetes. It has been shown that depression and diabetes-speciﬁc
emotional distress are differently associated with diabetes-speciﬁc
indicators, but this is mainly examined in persons with type 2 diabetes
[25–27].
Fisher et al. [18] found nonlinear relationships of diabetes-speciﬁc
emotional distress with HbA1c, diet, self-efﬁcacy, and physical activity
in two samples of persons with type 2 diabetes, with stronger relation-
ships for lower levels of diabetes-speciﬁc emotional distress. The
authors suggested that distress should be recognized at a lower level
than previously recommended, and further suggested that to split the
DDS scores into three groups (low, moderate and high distress) would
better accommodate to the signiﬁcant nonlinear relationship. Little
knowledge about a potential nonlinear association is available in
persons with type 1 diabetes, and it is not appropriate to assume that
emotional problems are similarlymanifested and have the same clinical
consequences in personswith type 1 and type 2 diabetes. Therefore, the
main aim of this study was to examine the relationships of diabetes-
speciﬁc emotional distress, anxiety, depression, and overall well-being
with HbA1c, and to determine whether there is a nonlinear relationship
between diabetes-related emotional distress and HbA1c in individuals
with type 1 diabetes.
Materials and methods
Sample and settings
Of the 319 persons with type 1 diabetes, aged 18–69 years, attending
an adult outpatient clinic between October 2008 and January 2009 who
were invited to participate in this study, 235 persons agreed to participate
(74%). Some information was available to compare participants with
nonparticipants: age (39.0 versus 37.9 years, respectively; P = .535),
sex distribution (male 57% versus 66%, respectively; P = .244) and
HbA1c level (8.1% (65 mmol/mol) versus 8.4% (68 mmol/mol), respec-
tively; P= .285). Sociodemographic and clinical information about the
study subjects are presented in Table 1. To determine HbA1c levels,
blood samples were taken at the time of data collection, and analyzed
with DCA-2000 Analyzer (Bayer, Elkhart, IN, USA).
Measures
The following questionnaires were included in the study. The
Problem Areas in Diabetes Survey (PAID) consists of 20 items and was
developed to gain insight into the breadth of emotional responses to
diabetes. It was initially based on a six-point Likert scale, rangingfrom 1 to 6 [19], but has been modiﬁed to a ﬁve-point Likert scale
ranging from 0 (not a problem) to 4 (a serious problem) [28]. The
questionnaire has been translated into Norwegian [29], and is consid-
ered internationally to have good psychometric properties [28–30]. A
total score of 0–100was computed,where higher scores represent higher
levels of distress [28].
The Diabetes Distress Scale (DDS)was developed to address some of
the limitations in earlier instruments that measured disease-speciﬁc
emotional distress, and consists of 17 items divided into four subscales:
the Emotional Burden subscale (EB, ﬁve items), Physician-related
Distress subscale (PD, four items), Regimen-related Distress subscale
(RD, ﬁve items), and diabetes-related Interpersonal Distress subscale
(ID, three items). The DDS is based on a six-point Likert scale, ranging
from 1 (no problem) to 6 (a serious problem) [20], and the measure
has been translated into Norwegian [29]. It has shown good psychomet-
ric properties across different countries and cultures [18,20,29]. A total
score of 0–100 was computed, where higher scores indicate greater
emotional distress [20]. For the nonlinearity analyses, scales scored
1–6 were computed to enable this part of the analysis to be more easily
compared with the Fisher et al. [18] results for nonlinearity in persons
with type 2 diabetes.
The Hospital Anxiety and Depression Scale (HADS)was designed for
clinicians as a screening test for psychiatric disorder in non-psychiatric
hospital departments [22]. It consists of two subscales, HADS-A
(anxiety) and HADS-D (depression), each with seven items with four-
point Likert scales, ranging from 0 to 3 [31], and 0–21 scales were
computed for HADS-A and HADS-D, where higher score indicates
worse anxiety or depression state. In a review study, Bjelland et al.
[32] found that the HADS performed well cross-culturally, and that its
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Norwegian version of the HADS showed to be satisfactory [33].
The World Health Organization-Five Well-Being Index (WHO-5)
was developed tomeasurewell-being [34], and consists of ﬁve positive-
ly worded items that assess well-being during the preceding 14 days,
with six-point Likert scales ranging from 0 (not present) to 5 (constantly
present). A total score of 0 (worst thinkable well-being) to 100 (best
thinkable well-being) was computed [35].
As recommended by Fayers and Machin [36], each scale score was
based on the mean of the valid items within each score if at least half
the items were valid, except for HADS, where at least 5 of 7 items had
to be valid. Cronbach's alphas for the respondents with type 1 diabetes
were DDS total 0.92, PAID total 0.95, WHO-5 0.89, HADS-A 0.81, HADS-D
0.81, DDS RD subscale 0.84, DDS EB subscale 0.88, DDS PD subscale 0.83,
and DDS ID subscale 0.81.Statistical analysis
Respondents that had any missing values on any of the explanatory
variables were excluded from regression analysis, giving a sample size
of n = 185.
HbA1c was the dependent variable in all analyses. To determine
whether there was any relationship of all indicators with HbA1c,
bivariate regression analyses of HbA1c with DDS total, PAID total,
each of the four DDS subscales, HADS-A, HADS-D, WHO-5 and each
of the adjustment variables age, sex, education and late complication
were performed (results for adjustment variables not shown). Next,
separate regression analyses were performed, one for each of the
total diabetes distress scales, each of the two HADS scales and the
overall well-being total scale, in addition to each of the four DDS sub-
scales, all adjusted for age, sex, education and late complications. In
the last phase, three models were estimated with multiple regres-
sion analyses adjusted for age, sex, education, and late complications
as well as HADS-A, HADS-D andWHO-5. The DDS total and PAID total
scales were analyzed in separate regression models because these
instruments measure parallel constructs. Because the DDS subscales
measure quite different areas of diabetes-speciﬁc emotional distress
[20] the four subscales were analyzed together in the last regression
model. Multicollinearity in the multiple regression models was
checked by variance inﬂation factor (VIF). A sensitivity analysis
using multiple imputation (200 imputed data sets) was performed
to test whether the results from the complete case regression analy-
ses described above were biased.
The potential nonlinear relationship between diabetes-speciﬁc
emotional distress and glycemic control in the 185 persons with type
1 diabetes was addressed using regression analysis with restricted
cubic splines with four knots (requiring 3 degrees of freedom) to
incorporate possibly nonlinear relationships [37]. Because Fisher et al.
[18] used quadratic regression analyses in their study, supplementary
analyses of nonlinearity were performed with quadratic regression
analysis to assure that potential differences between our study and
the Fisher et al. study were not a consequence of methodological
differences. As done in the linear analysis, the DDS total (1–6 scale)
and PAID total were analyzed in separate regression models. Even
though the four DDS subscales were integrated into one model in the
linear analysis, the lower number of degrees of freedom in the nonlinear
analysis made it necessary to analyze the four DDS subscales in four
separate models when testing for nonlinearity. The nonlinear analyses
were adjusted for the WHO-5 score, HADS scores, sex, age, education,
and late complications.
Signiﬁcance was deﬁned as P b .05 in all analyses. The linear regres-
sions were analyzed with SPSS version 19/20 (IBM, Armonk, NY), the
nonlinear analysis were performed in the R (The R Foundation for Statis-
tical Computing, Vienna, Austria) package rms and multiple imputation
in the R package mice.Ethical considerations
The study was approved by the Western Norway Committee for
Medical and Health Research Ethics (19580/865). Participants got
written and oral information about the study, and were informed that
they could withdraw at any point of time.
Results
Linear regression analysis
The following variables were signiﬁcantly related with HbA1c in the bivariate
regression analysis (Table 2): PAID and DDS total scores (unstandardized coefﬁcient
0.020, P= .001, and 0.033, P b .001, respectively); regimen-related distress DDS subscale
and the emotional burden DDS subscale (0.039, P b .001 and 0.014, P= .005, respective-
ly); HADS-A, HADS-D and WHO-5 were not. Further, the presence of one or more late
complications (0.621, P= .010) and lower level of educationwere signiﬁcantly associated
with higherHbA1c (P= .025). Age and genderwere not signiﬁcantly relatedwithHbA1c in
the bivariate regression.
When analyzing the indicators in separate analyses, all controlled for age, sex,
education and late complications, results were similar to the bivariate regression results
for PAID total and DDS total (signiﬁcant) and HADS-A, HADS-D and WHO-5 (not
signiﬁcant). For the DDS subscales, the regimen-related distress and emotional burden
were signiﬁcant (0.038, P b .001 and 0.011, P= .036, respectively).
In the fully adjusted multiple regression analyses, both the DDS total score
(0.038, P b .001) and PAID total score (0.021, P= .007) were signiﬁcantly associated
with glycemic control. In the model including the four DDS subscales, only the RD
subscale was signiﬁcantly associated with HbA1c (0.056, P b .001). The model includ-
ing DDS total explained 20.3% (R2), and the model including PAID total explained
15.0% (R2), of the variation in HbA1c. The DDS subscale model explained 38.6% (R2)
of the variation in HbA1c. Overall well-being, depression or anxiety was not signiﬁ-
cantly related to HbA1c in any of these models. The maximum VIF was 2.92, and the
results from the sensitivity analysis using multiple imputation showed only minor
differences.
Peyrot et al. [38] suggested the use of 0.5 standard deviation (SD) as the minimum
detectable difference (MDD), an estimate of the smallest change that can be subjectively
realized by individuals [39]. A difference of 0.5 SD (of baseline mean, Table 1) in PAID
total and DDS total is associated with a difference of 0.2 and 0.3 in HbA1c, respectively. A
difference of 0.5 SD in the regimen-related emotional distress (RD subscale) is associated
with a difference of 0.6 in HbA1c. Thus, persons who perceived that their regimen related
distress had noticeably increased might be expected to experience an increase of 0.6 in
their HbA1c.
Nonlinear analyses
No signiﬁcant nonlinear relationship was found between diabetes-speciﬁc emotional
distress and glycemic control; P for nonlinearity = 0.317 in the model based on the DDS
total and P for nonlinearity = 0.309 in the model based on the PAID total. Also, graphs
of the estimated relationships did not indicate deviations from linearity. Moreover, no
signiﬁcant nonlinear relationships were found between the four DDS subscales and
HbA1c; P for nonlinearity = 0.322 (RD), 0.464 (EB), 0.505 (ID) and 0.186 (PD). Results
from the supplementary analysis with quadratic regression analysis showed similar
results, where no signiﬁcant nonlinear relationships between diabetes-speciﬁc emotional
distress and HbA1c were apparent, with P for nonlinearity of 0.126 (DDS total), 0.112
(PAID total), 0.162 (RD subscale), 0.215 (EB subscale), 0.579 (ID subscale) and 0.060
(PD subscale).
Discussion
This study appears to be the ﬁrst to demonstrate that among adults
with type 1 diabetes, depression, anxiety, and overall well-being were
not signiﬁcantly related with glycemic control but there were
signiﬁcant associations between diabetes-speciﬁc emotional distress
and HbA1c. The Diabetes Distress Scale total score was more strongly
associated than the PAID total score, and regimen-related DDS subscale
showed the strongest relationship with HbA1c (regression coefﬁcients
and R2). There was no signiﬁcant nonlinearity in the relationship
between diabetes-speciﬁc emotional distress and HbA1c.
Fisher et al. [27] and Gonzales et al. [17] expressed concern that
diabetes-speciﬁc emotional distress might be interpreted as depression
and addressed with care strategies based on the depression literature.
The associations of depression or diabetes-speciﬁc emotional distress
with glycemic control have been examined predominantly in persons
with type 2 diabetes, where Fisher et al. [25,26] found a signiﬁcant
relationship of glycemic control with diabetes-speciﬁc emotional
Table 2
Associations of diabetes-speciﬁc emotional distress, anxiety, depression and overall well-being with HbA1c.
Bivariate regression Regression with partial adjustmentc Regression with full adjustmentd
Coefﬁcienta CI P Coefﬁcienta CI P Coefﬁcienta CI Coefﬁcientb P
PAID total 0.020 0.008–0.032 .001 0.017 0.004–0.029 .009 0.021 0.006–0.036 0.244 .007
WHO-5 −0.003 −0.021–0.015 −0.035 .759
HADS-A −0.028 −0.115–0.059 −0.064 .527
HADS-D −0.032 −0.133–0.070 −0.069 .540
R2/adjusted R2 5.4%/4.9% 14.3%/11% 15.0%/10.1%
DDS total 0.033 0.019–0.047 b .001 0.030 0.015–0.044 b .001 0.038 0.021–0.055 0.374 b .001
WHO-5 0.001 −0.017–0.018 0.011 .920
HADS-A −0.048 −0.133–0.036 −0.112 .261
HADS-D −0.025 −0.123–0.073 −0.054 .618
R2/adjusted R2 10.8%/10.3% 18.6%/15.4% 20.3%/15.7%
DDS EB 0.014 4.2%/3.7%e 0.004–0.025 .005 0.011 13.2%/9.7%e 0.001–0.021 .036 −0.013 −0.027–0 .001 −0.188 .067
DDS RD 0.039 26.9%/26.5%e 0.030–0.049 b .001 0.038 32.6%/29.9%e 0.028–0.048 b .001 0.056 0.043–0.069 0.734 b .001
DDS ID 0.010 1.2%/0.6%e −0.003–0.023 .140 0.009 11.9%/8.4%e −0.004–0.022 .191 −0.010 −0.024−0.004 −0.108 .161
DDS PD 0.007 0.4%/–0.1%e −0.009–0.024 .370 0.006 11.3%/7.8%e −0.010–0.022 .431 0.000 −0.017–0.017 −0.002 .976
WHO-5 −0.010 1.4%/0.9%e −0.021–0.002 .106 −0.005 11.3%/7.8%e −0.017–0.008 .455 0.007 −0.009–0.023 0.085 .392
HADS-A 0.027 0.4%/−0.1%e −0.036–0.091 .392 0.014 11.1%/7.6%e −0.051–0.079 .673 −0.018 −0.094–0.058 −0.042 .635
HADS-D 0.014 0.1%/−0.4%e −0.052–0.081 .672 0.010 11.0%/7.5%e −0.058–0.079 .772 −0.012 −0.099–0.075 −0.026 .785
R2/adjusted R2 38.6%/34%
a Unstandardized regression coefﬁcients.
b Standardized regression coefﬁcients.
c PAID total, DDS total, EB, RD, ID, PD, HADS-A, HADS-D and WHO-5 in separate regression models, each adjusted by age, sex, education and late complications.
d Multiple regression analysis of PAID total, DDS total in separate models, adjusted for age, sex, education, late complications, HADS and WHO-5, then the four DDS subscales in one
separate model adjusted with the similar control variables.
e R2 and adjusted R2 in the bivariate regression and the partly adjusted regression.
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diabetes showing similar relationships support that diabetes-speciﬁc
emotional distress and depression should be recognized as different
conditions in clinical consultation in type 1 diabetes [11]. Fisher et al.
[40] proposed that emotional distress is a core construct underlying
diabetes-speciﬁc emotional distress and depression (from depressive
symptoms to major depressive disorders), and emphasized that health
care providers should acknowledge the difference between the severity
and content of emotional distress in clinical consultations. Our study
cannot determine whether depression and diabetes-speciﬁc emotional
distress are different entities, or whether the differing relationships of
glycemic control with depression or diabetes-speciﬁc emotional
distress are due to differences in severity or content of emotional
problems, but both possibilities are worth considering.
Aikens [11] suggested that diabetes-speciﬁc emotional distress
(measured with the PAID), rather than depression, might derive from
activities strongly related to diabetes and its treatment, and disrupt
self-care activities that are directly linked to the disease, whereas
depression might disrupt more lifestyle-oriented behaviors. Using the
DDS creates an opportunity to examine the role of speciﬁc domains of
diabetes-related emotional distress. Regimen-related distress was
the only distress domain associated with HbA1c in the fully adjusted
analysis. In the bivariate regression and the partly adjusted regression
analysis, the EB subscalewas also signiﬁcantly related toHbA1c although
not when controlling for the RD subscale and the other indicators.
Therefore, we suggest that it may be distress related to the self-care
demands of the treatment regimen that actually drives the relationship
between diabetes-speciﬁc emotional distress and HbA1c. Hessler et al.
[41] showed that reductions in regimen distress were associated with
improved glycemic control over time for persons with type 2 diabetes,
and emphasized the importance of addressing regimen distress as part
of diabetes care. Reddy et al. [42] suggested that the PAID might be
useful as a screening tool of diabetes-speciﬁc emotional distress in
clinical consultation, but results from our study suggest that the DDS
might be more appropriate to capture distress regarding the
self-management behaviors of diabetes, as the PAID does not provide
a validated measure of regimen distress which seems to be the most
important component of diabetes-speciﬁc distress.
In our study, the positively worded measure of overall well-being
was not signiﬁcantly related to glycemic control. Moskowitz et al. [43]showed that positive affect was a unique predictor of mortality in
persons with diabetes, and argued for the value of addressing positive
affect in clinical consultation. Indeed the literature review of Robertson
et al. [44] suggested that positive emotional health might facilitate bet-
ter self-management and improved health outcomes. A systematic re-
view of qualitative research studies of factors inﬂuencing ability to
self-management in type 1 and type 2 diabetes concluded that the
wider picture beyond the physical manifestation of diabetes must be
taken into consideration [45]. Nevertheless, results from our study
suggest that a measure of overall well-being is too generic to reveal an
association with the particular outcome of glycemic control, and that
well-being must integrate some disease-speciﬁc elements if relation-
ships to speciﬁc biomedical outcomes are to be discovered. A recent
study of severe hypoglycemia and psychological well-being supports
this interpretation [46]. The authors found that neither generic overall
well-being, nor diabetes-speciﬁc emotional distress (measured by the
PAID) was signiﬁcantly related to hypoglycemia, whereas diabetes-
speciﬁc positive well-being was signiﬁcantly related to hypoglycemia.
Moreover, Snoek et al. [47] found that individual care strategies for
people with type 1 and type 2 diabetes improved the scale scores of
diabetes-speciﬁc emotional distress but not overall well-being.
A signiﬁcant nonlinear relationship between diabetes-speciﬁc
emotional distress and glycemic control was not found in this study,
similar to results shown in the recent cross-sectional study of Joensen
et al. [48]. That such a relationship was not identiﬁed in these studies
of adults with type 1 diabetes, in conjunctionwith its presence in adults
with type 2 diabetes [18], might indicate that emotional problems have
different implications for persons with type 1 and type 2 diabetes. The
ﬁndings of a signiﬁcant relationship between distress and glycemic
control, and the lack of signiﬁcant nonlinearity, suggest that interventions
addressing diabetes distress might be applied at any non-zero level of
diabetes distress, although this should be further investigated in larger
samples.
There were some limitations to this study. First, because it was a
cross-sectional study, no inferences about a causal effect between
diabetes-related emotional distress and HbA1c can be drawn. We do
not knowwhether the association between diabetes-speciﬁc emotional
distress and HbA1c is a direct causal relationship, nor which direction a
causal relationship might take, nor whether there might be an underly-
ing mechanism that inﬂuences both diabetes-speciﬁc emotional
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dinal studies of the relationship between glycemic control and diabetes-
speciﬁc emotional distress in type 1 diabetes are warranted. As the
regimen-related emotional distress seems to be an active ingredient in
the relationship between diabetes-speciﬁc distress and HbA1c, potential
underlying mechanisms of this association (especially regimen
adherence behavior) need to be further examined in future studies.
A second limitation is that all the information about symptoms of
depression and anxiety were self-reported because no diagnostic
information was available, and few respondents reported the highest
scores on the HADS. The study may therefore have underestimated
the potential impact of these factors among persons with more severe
depression and anxiety. In addition, the HADS has been criticized as a
measure of depression [49,50]. However, a study investigating the
cross-sectional and longitudinal relationship between depression and
glycemic control using a diagnostic interview (CIDI) based on the
DSM-IV criteria also did not ﬁnd a signiﬁcant relationship between
depression and glycemic control [26].
We have shown that glycemic control in adults with type 1 diabetes
was not signiﬁcantly associated with depression, anxiety, and overall
well-being, but was signiﬁcantly associated with diabetes-speciﬁc
emotional distress, especially that regarding the treatment regimen.
Gonzales et al. [17] argue that the recognition of the content of
diabetes-speciﬁc emotional distress in clinical consultations might
require only a small shift in the perspective of the clinician. A recent
systematic review of emotional health and diabetes self-care emphasized
that talking about the persons' thoughts and understanding of the disease
in clinical consultation might make it easier for health care providers to
recognize those in poor emotional health [51]. Yet Beverly et al. [52]
showed that 30% of their sample of persons with type 1 and type 2
diabetes were reluctant to discuss self-care in clinical consultation, and
that reluctant persons reported less frequent self-care, higher diabetes-
speciﬁc emotional distress andmore depressive- and anxiety symptoms;
these ﬁndings illustrate the complexity of the interaction between the
clinician and the persons with diabetes in clinical consultation. Our
study highlights that addressing distress related to the disease during
clinical consultation would enable greater insight into whether such
distress is apparent, andwhat speciﬁcally this distressmight be constituted
of for the individual person. In particular, addressing distress related to
the treatment regimen and self-care demands might give health care
providers information necessary to assist the person in bettering their
diabetes self-management. If change in glycemic control is targeted,
focusing on diabetes-speciﬁc emotional distress may yield greater
improvement than focusing solely on attaining overall well-being.
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